REDHILL BIOPHARMA LTD. Number Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement
REDHILL BIOPHARMA LTD. (RDHL) reported Number Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement of 23.94 thousand shares for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-10.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement · last filed 2025-04-10
EquityInstruments
| Period end | Number Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement 12 month | Number Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement 12 month as first filed |
|---|---|---|
| 2023-12-31 | 66.46K EquityInstruments 20-F · filed 2024-04-08 | |
| 2022-12-31 | 12.16K EquityInstruments 20-F · filed 2024-04-08 | 486.50K EquityInstruments 20-F · filed 2023-04-28 |
shares
| Period end | Number Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement 12 month |
|---|---|
| 2024-12-31 | 23.94K shares 20-F · filed 2025-04-10 |
| 2023-12-31 | 2.66K shares 20-F · filed 2025-04-10 |